225 related articles for article (PubMed ID: 33450878)
41. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
Herbert BS; Pongracz K; Shay JW; Gryaznov SM
Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
[TBL] [Abstract][Full Text] [Related]
42. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
43. Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo.
Shi JB; Chen LZ; Wang Y; Xiou C; Tang WJ; Zhou HP; Liu XH; Yao QZ
Eur J Med Chem; 2016 Nov; 124():729-739. PubMed ID: 27639364
[TBL] [Abstract][Full Text] [Related]
44. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo.
Cai Y; Xia Q; Luo R; Huang P; Sun Y; Shi Y; Jiang W
J Nat Med; 2014 Jan; 68(1):53-62. PubMed ID: 23604974
[TBL] [Abstract][Full Text] [Related]
45. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
47. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
48. Antiproliferative and Antitelomerase Effects of Silymarin on Human Colorectal and Hepatocellular Carcinoma Cells.
Rahimi D; Sharifi R; Jaberie H; Naghibalhossaini F
Planta Med; 2024 Apr; 90(4):298-304. PubMed ID: 38219733
[TBL] [Abstract][Full Text] [Related]
49. Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity.
Zhu Z; Tran H; Mathahs MM; Fink BD; Albert JA; Moninger TO; Meier JL; Li M; Schmidt WN
Pharmacol Res Perspect; 2021 Dec; 9(6):e00882. PubMed ID: 34747573
[TBL] [Abstract][Full Text] [Related]
50. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
[TBL] [Abstract][Full Text] [Related]
51. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
Zhang RG; Zhang RP; Wang XW; Xie H
Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
[TBL] [Abstract][Full Text] [Related]
52. Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety.
Han X; Yu YL; Ma D; Zhang ZY; Liu XH
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):344-360. PubMed ID: 33356666
[TBL] [Abstract][Full Text] [Related]
53. In vitro modulation of telomerase activity, telomere length and cell cycle in MKN45 cells by verbascoside.
Zhang F; Jia Z; Deng Z; Wei Y; Zheng R; Yu L
Planta Med; 2002 Feb; 68(2):115-8. PubMed ID: 11859459
[TBL] [Abstract][Full Text] [Related]
54. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
Tamakawa RA; Fleisig HB; Wong JM
Cancer Res; 2010 Nov; 70(21):8684-94. PubMed ID: 20837664
[TBL] [Abstract][Full Text] [Related]
55. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
Shammas MA; Koley H; Beer DG; Li C; Goyal RK; Munshi NC
Gastroenterology; 2004 May; 126(5):1337-46. PubMed ID: 15131795
[TBL] [Abstract][Full Text] [Related]
56. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.
Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L
Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300
[TBL] [Abstract][Full Text] [Related]
57. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471
[TBL] [Abstract][Full Text] [Related]
58. Targeted Covalent Inhibition of Telomerase.
Betori RC; Liu Y; Mishra RK; Cohen SB; Kron SJ; Scheidt KA
ACS Chem Biol; 2020 Mar; 15(3):706-717. PubMed ID: 32017522
[TBL] [Abstract][Full Text] [Related]
59. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
[TBL] [Abstract][Full Text] [Related]
60. Effects of in vitro short- and long-term treatment with telomerase inhibitor in U-251 glioma cells.
Andrade da Mota TH; Reis Guimarães AF; Silva de Carvalho AÉ; Saldanha-de Araujo F; Pinto de Faria Lopes G; Pittella-Silva F; do Amaral Rabello D; Madureira de Oliveira D
Tumour Biol; 2021; 43(1):327-340. PubMed ID: 34957975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]